Safety Evaluation of EGFR-TKI Therapy in Patients with Non-Small Cell Lung Cancer: A Real-World Study Based on theFAERS Database. Clinical Medicine and Pharmacology, [S. l.], v. 3, n. 2, p. 1–13, 2026. DOI: 10.70731/0yk94f55. Disponível em: https://jandoopress.com/journal/cmp/article/view/242. Acesso em: 30 may. 2026.